
|Videos|May 2, 2021
Investigating the low vulnerability of posterior eye segment to SARS-CoV-2
Author(s)OT Staff Reports
Steffen E. Künzel, MD, discusses the key points of his research presentation regarding low vulnerability of the posterior eye segment to SARS-CoV-2 infection.
Advertisement
Steffen E. Künzel, MD, from the Department of Ophthalmology Charité University Medicine Berlin, Berlin, Germany, discusses the key points of his research presentation on low vulnerability of the posterior eye segment to SARS-CoV-2 infection during the virtual 2021 ARVO meeting.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
AAO 2025 Takeaways: The next frontier in retinal therapeutics arrives
2
AGC Biologics to manufacture AAVantgarde’s dual-vector gene therapies, AVB-039 and AAVB-081
3
Ocular Therapeutix randomizes first patient in HELIOS-3
4
AAO 2025 Takeaways: How imaging and remote monitoring are transforming retinal care
5


















































.png)


